Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Amentum reports after the close, meaning Day 0 reflects anticipatory trading before results are released, while Day +1 captures the market's first full reaction to the actual earnings.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-08-10 | -$0.33 (-1.33%) | $0.69 (2.79%) | -$2.01 (-8.22%) | $1.69 (6.91%) |
| 2026-05-11 | -$0.59 (-2.41%) | $1.39 (5.67%) | +$0.37 (+1.55%) | $1.70 (7.10%) |
| 2026-02-09 | -$0.94 (-2.50%) | $1.38 (3.67%) | -$4.53 (-12.38%) | $2.60 (7.11%) |
| 2025-11-24 | +$1.11 (+4.58%) | $1.41 (5.80%) | +$4.63 (+18.25%) | $4.31 (16.99%) |
| 2025-08-05 | +$0.83 (+3.39%) | $1.29 (5.27%) | +$0.43 (+1.70%) | $2.18 (8.61%) |
| 2025-05-06 | +$0.28 (+1.28%) | $0.79 (3.60%) | -$1.00 (-4.52%) | $1.89 (8.55%) |
| 2025-02-04 | +$0.10 (+0.49%) | $0.85 (4.17%) | +$2.18 (+10.63%) | $2.14 (10.44%) |
| 2024-12-16 | +$0.73 (+3.17%) | $1.39 (6.01%) | -$2.27 (-9.55%) | $4.31 (18.12%) |
| Avg Abs Move | 2.39% | 4.62% | 8.35% | 10.48% |
Amentum's post-earnings price action has been highly volatile, with an average absolute Day 0 move of 2.39% and a much larger Day +1 move averaging 8.35%. The Day +1 range averages 10.48%, indicating substantial intraday volatility following the release.
The most dramatic reaction came after the November 2025 report, when the stock surged 18.25% on Day +1 with a range of 16.99%. Conversely, the February 2026 report triggered a -12.38% Day +1 decline. More recently, the August 2026 report saw a -8.22% Day +1 move despite a modest -1.33% Day 0 reaction.
The wide disparity between Day 0 and Day +1 moves suggests that initial market reactions are often muted, with the real price discovery occurring once investors digest the full earnings details and management commentary. Investors should be prepared for significant volatility in the session following the release, with historical moves ranging from double-digit gains to double-digit losses.
| Metric | Value |
|---|---|
| Expiration Date | 12/18/26 (DTE 28) |
| Expected Move | $2.70 (13.25%) |
| Expected Range | $17.70 to $23.10 |
| Implied Volatility | 63.06% |
The options market is pricing a 13.25% expected move for the December 2026 expiration, which is notably higher than Amentum's average historical Day +1 move of 8.35% but below the 10.48% average Day +1 range. This suggests options traders are anticipating above-average volatility for this earnings release, consistent with the heightened uncertainty around margin trends and the disconnect between contract wins and near-term profitability.
Amentum currently holds an average analyst rating of 3.69 (between Hold and Buy), with 4 Strong Buy ratings, 1 Moderate Buy, 8 Hold ratings, and no Sell ratings among the 13 analysts covering the stock.
The consensus average price target of $29.25 implies 43.8% upside from the current price of $20.34, with a high target of $40.00 and a low of $20.00. This wide range reflects divergent views on the company's ability to convert its contract backlog into earnings growth.
Analyst sentiment has improved over the past month, with one analyst upgrading from Strong Sell to Hold. The rating moved from 3.54 one month ago to the current 3.69, indicating a modest shift toward a more constructive view.
However, recent price target activity tells a more cautious story. Multiple firms have trimmed targets in recent months, including JPMorgan (lowered to $26 from $31), Morgan Stanley (cut to $24 from $30), and Bank of America (reduced to $30 from $35). RBC Capital recently lowered its target to $25 from $26 while maintaining a Sector Perform (Hold) rating. These cuts reflect concerns about organic growth, margin trends relative to peers, and sector-wide derating, even as analysts acknowledge the company's solid bookings and free cash flow generation.
Bullish analysts emphasize Amentum's strong contract pipeline, 1.2 book-to-bill ratio, and free cash flow generation as supportive of deleveraging and long-term value creation. Citizens analyst Trevor Walsh raised his price target to $40 from $35, highlighting the company's expanding nuclear and defense portfolios. Conversely, bearish analysts point to expectations for slower organic growth and margins versus peers like SAIC and Leidos, with one Underperform rating citing a view that only modest margin expansion beyond the current 8% level is likely.
The Barchart Technical Opinion currently shows a 48% Sell signal, a sharp reversal from last week's 8% Buy signal and slightly more bearish than last month's 40% Sell reading. This rapid deterioration reflects recent price weakness as the stock has declined heading into earnings.
Timeframe Analysis:
Trend Characteristics: The trend is characterized as Weak and Weakening, indicating deteriorating momentum and a lack of conviction from buyers heading into the earnings release.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $21.00 | 50-Day MA | $20.32 |
| 10-Day MA | $21.73 | 100-Day MA | $20.83 |
| 20-Day MA | $21.82 | 200-Day MA | $23.45 |
The stock is currently trading at $20.34, positioned below its 5-day ($21.00), 10-day ($21.73), 20-day ($21.82), 100-day ($20.83), and 200-day ($23.45) moving averages. The only support comes from the 50-day moving average at $20.32, which the stock is trading just above.
This technical setup is decidedly bearish, with the stock trapped below multiple resistance levels and trading near its 52-week low of $17.72. The 200-day moving average at $23.45 represents significant overhead resistance, more than 15% above current levels. The weak technical picture suggests limited near-term support, and a disappointing earnings report could push the stock toward retesting its yearly lows. Conversely, a strong beat with positive guidance could trigger a sharp reversal given the oversold conditions and heavy short-term bearish positioning.